All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ROYALTY PHARMA PLC Last Reported: 5/31/2024 Stock Symbol: RPRX

Business Address

110 EAST 59TH STREET

NEW YORK , NY US 10022

Mailing Address

110 EAST 59TH STREET

NEW YORK , NY US 10022
Phone Number: (212) 883-0200 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 12/31/2019 9/30/2019 6/30/2019 12/31/2018 12/31/2017
Cash and Cash Equivalents $843,000,000.00 $477,010,000.00 $936,448,000.00 $2,173,077,000.00 $1,975,689,000.00 $1,710,751,000.00 $991,628,000.00 $2,108,037,000.00 $1,791,517,000.00 $1,541,048,000.00 $1,800,808,000.00 $1,142,281,000.00 $708,810,000.00 $1,008,680,000.00 $1,552,802,000.00 $2,443,430,000.00 $246,199,000.00 -- -- $1,924,211,000.00 --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $1,559,719,000.00 $1,274,193,000.00 $1,728,605,000.00 $2,953,539,000.00 $2,631,221,000.00 $2,554,908,000.00 $2,342,116,000.00 $3,503,849,000.00 $2,982,418,000.00 $2,878,211,000.00 $2,775,761,000.00 $2,707,454,000.00 $2,416,024,000.00 $2,696,898,000.00 $2,783,851,000.00 $3,390,789,000.00 $832,072,000.00 -- -- $2,608,554,000.00 --
Property Plant and Equipement -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $4,488,000.00 $6,522,000.00 $20,212,000.00 $29,408,000.00 $28,030,000.00 $29,629,000.00 $30,613,000.00 $33,412,000.00 $3,870,000.00 $4,145,000.00 $4,515,000.00 $5,960,000.00 $4,256,000.00 $23,158,000.00 $4,891,000.00 -- $45,600,000.00 -- -- -- --
Total Assets $16,130,886,000.00 $16,381,851,000.00 $15,855,524,000.00 $17,121,482,000.00 $17,074,121,000.00 $16,813,466,000.00 $17,672,605,000.00 $17,740,413,000.00 $17,378,888,000.00 $17,515,865,000.00 $17,732,358,000.00 $16,514,913,000.00 $15,914,088,000.00 $16,020,286,000.00 $15,990,678,000.00 $15,685,556,000.00 $12,449,895,000.00 -- -- $11,370,147,000.00 --
Accounts Payable -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $6,267,170,000.00 $6,297,562,000.00 $6,270,427,000.00 $7,307,796,000.00 $7,252,121,000.00 $7,288,093,000.00 $7,256,202,000.00 $7,332,226,000.00 $7,237,009,000.00 $7,267,320,000.00 $7,345,724,000.00 $6,109,548,000.00 $6,077,055,000.00 $6,124,471,000.00 $6,192,030,000.00 $6,290,595,000.00 $6,308,457,000.00 -- -- $6,818,068,000.00 --
Long Term Debt $6,139,376,000.00 $6,135,285,000.00 $6,131,194,000.00 $7,126,444,000.00 $7,121,383,000.00 $7,116,322,000.00 $7,111,260,000.00 $7,106,199,000.00 $7,101,138,000.00 $7,096,070,000.00 $7,090,669,000.00 $5,825,559,000.00 $5,821,072,000.00 -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- $16,904,000.00 $13,177,000.00 $12,304,000.00 $16,491,000.00 $20,553,000.00 $28,672,000.00 $29,452,000.00 $34,395,000.00 $34,746,000.00 $30,515,000.00 $2,093,000.00 -- -- $-10,255,000.00 --
Accumulated Deficit $2,427,448,000.00 $2,517,583,000.00 $2,134,680,000.00 $2,252,945,000.00 $2,216,811,000.00 $1,964,689,000.00 $2,504,974,000.00 $2,446,132,000.00 $2,224,677,000.00 $2,255,179,000.00 $2,320,878,000.00 $2,291,966,000.00 $1,923,771,000.00 $1,920,635,000.00 $1,807,146,000.00 $1,571,399,000.00 $2,825,212,000.00 -- -- $1,215,953,000.00 --
Total Stockholders' Equity -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Controlling Interest in Subsidiaries $3,363,965,000.00 $3,557,792,000.00 $3,446,175,000.00 $3,532,019,000.00 $3,868,251,000.00 $3,897,223,000.00 $4,264,303,000.00 $4,380,938,000.00 $4,364,324,000.00 $4,471,951,000.00 $4,593,564,000.00 $4,671,686,000.00 $4,954,818,000.00 $5,077,036,000.00 $5,346,835,000.00 $5,237,829,000.00 $35,883,000.00 -- -- $63,865,000.00 --
Total Liabilities and Equity $16,130,886,000.00 $16,381,851,000.00 $15,855,524,000.00 $17,121,482,000.00 $17,074,121,000.00 $16,813,466,000.00 $17,672,605,000.00 $17,740,413,000.00 $17,378,888,000.00 $17,515,865,000.00 $17,732,358,000.00 $16,514,913,000.00 $15,914,088,000.00 $16,020,286,000.00 $15,990,678,000.00 $15,685,556,000.00 $12,449,895,000.00 -- -- $11,370,147,000.00 --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 12/31/2019 9/30/2019 6/30/2019 12/31/2018 12/31/2017
Total Revenues $567,978,000.00 $2,354,554,000.00 $1,758,486,000.00 $538,202,000.00 $683,971,000.00 $2,237,215,000.00 $1,671,467,000.00 $1,098,004,000.00 $562,049,000.00 $2,289,463,000.00 $1,713,763,000.00 $1,127,990,000.00 $573,027,000.00 $2,122,353,000.00 $1,550,210,000.00 $510,932,000.00 $1,814,254,000.00 $1,356,768,000.00 $457,608,000.00 $1,794,894,000.00 $1,597,930,000.00
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $500,000.00 $52,000,000.00 $50,500,000.00 $1,000,000.00 $500,000.00 $177,106,000.00 $126,600,000.00 $600,000.00 $100,500,000.00 $200,100,000.00 $96,263,000.00 $5,763,000.00 $2,641,000.00 $26,289,000.00 $18,510,000.00 $13,415,000.00 $83,036,000.00 $67,166,000.00 $44,448,000.00 $392,609,000.00 $117,866,000.00
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-73,774,000.00 $1,492,150,000.00 $879,254,000.00 $248,840,000.00 $478,972,000.00 $307,065,000.00 $192,210,000.00 $377,792,000.00 $219,718,000.00 $1,430,715,000.00 $303,052,000.00 $974,247,000.00 $229,297,000.00 $1,595,399,000.00 $1,281,344,000.00 $770,776,000.00 $2,623,176,000.00 $1,291,257,000.00 $758,759,000.00 $1,364,446,000.00 $939,692,000.00
Loss Before Income Taxes $-4,273,000.00 $1,700,088,000.00 $982,502,000.00 $860,425,000.00 $509,089,000.00 $230,064,000.00 $840,094,000.00 $619,680,000.00 $128,083,000.00 $1,241,201,000.00 $1,187,530,000.00 $965,734,000.00 $158,979,000.00 $1,701,954,000.00 $1,335,326,000.00 $711,072,000.00 $2,461,419,000.00 $1,014,891,000.00 $574,864,000.00 $1,517,855,000.00 $1,343,180,000.00
Earnings Per Share Basic $0.01 $2.54 $1.43 $1.27 $0.76 $0.10 $1.14 $0.82 $0.12 $1.49 $0.24 $1.28 $0.18 $1.32 $0.88 $0.09 -- -- -- -- --
Weighted Average Shares Basic 448,623,000 447,601,000 448,439,000 448,022,000 445,612,000 437,963,000 439,293,000 436,318,000 433,956,000 414,794,000 409,253,000 399,606,000 389,760,000 375,444,000 367,753,000 353,979,000 -- -- -- -- --
Earnings Per Share Diluted $0.01 $2.53 $0.16 $1.27 $0.76 $0.10 $1.14 $0.82 $0.12 $1.49 $1.49 $1.25 $0.18 $1.32 $0.88 $0.09 -- -- -- -- --
Weighted Average Shares Diluted 597,479,000 602,900,000 604,717,000 605,860,000 607,251,000 437,972,000 607,209,000 607,207,000 607,201,000 414,802,000 607,174,000 607,151,000 607,148,000 375,455,000 367,756,000 353,980,000 -- -- -- -- --
Common Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com